HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1001	17 JACOBSON S, Trojanowski JQ AMYGDALOID PROJECTIONS TO PREFRONTAL GRANULAR CORTEX IN RHESUS-MONKEY DEMONSTRATED WITH HORSERADISH-PEROXIDASE BRAIN RESEARCH. 1975; 100 (1): 132-139	66	66	1	23
1002	2802 RODER HM, EDEN PA, INGRAM VM BRAIN PROTEIN-KINASE PK40(ERK) CONVERTS TAU INTO A PHF-LIKE FORM AS FOUND IN ALZHEIMERS-DISEASE BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1993 JUN 15; 193 (2): 639-647	66	108	17	34
1003	3678 CHOILUNDBERG DL, BOHN MC ONTOGENY AND DISTRIBUTION OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) MESSENGER-RNA IN RAT DEVELOPMENTAL BRAIN RESEARCH. 1995 MAR 16; 85 (1): 80-88	66	172	1	16
1004	4320 BueeScherrer V, Hof PR, Buee L, Leveugle B, Vermersch P, et al. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease ACTA NEUROPATHOLOGICA. 1996 APR; 91 (4): 351-359	66	85	21	54
1005	5193 Liu XZ, Xu XM, Hu R, Du C, Zhang SX, et al. Neuronal and glial apoptosis after traumatic spinal cord injury JOURNAL OF NEUROSCIENCE. 1997 JUL 15; 17 (14): 5395-5406	66	396	2	79
1006	5560 Price DL, Tanzi RE, Borchelt DR, Sisodia SS Alzheimer's disease: Genetic studies and transgenic models ANNUAL REVIEW OF GENETICS. 1998; 32: 461-493	66	231	30	226
1007	5877 Vaughan JR, Farrer MJ, Wszolek ZK, Gasser T, Durr A, et al. Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations HUMAN MOLECULAR GENETICS. 1998 APR; 7 (4): 751-753	66	99	1	14
1008	6324 Canu N, Dus L, Barbato C, Ciotti MT, Brancolini C, et al. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis JOURNAL OF NEUROSCIENCE. 1998 SEP 15; 18 (18): 7061-7074	66	140	23	71
1009	6867 Kim JYH, Sutton ME, Lu DJ, Cho TA, Goumnerova LC, et al. Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas CANCER RESEARCH. 1999 FEB 1; 59 (3): 711-719	66	92	6	59
1010	10919 Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, et al. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters JOURNAL OF NEUROSCIENCE RESEARCH. 2002 JUN 1; 68 (5): 568-578	66	77	26	44
#	Date / Author / Journal	LCS	GCS	LCR	CR
1011	13178 Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, et al. Interactions among alpha-synuclein, dopamine, and biomembranes - Some clues for understanding neurodegeneration in Parkinson's disease JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 23 (1-2): 23-33	66	98	45	55
1012	13495 Lee HJ, Khoshaghideh F, Patel S, Lee SJ Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway JOURNAL OF NEUROSCIENCE. 2004 FEB 25; 24 (8): 1888-1896	66	92	30	53
1013	14226 Alonso AD, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K Promotion of hyperphosphorylation by frontotemporal dementia tau mutations JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 AUG 13; 279 (33): 34873-34881	66	76	45	62
1014	14472 Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease NEUROLOGY. 2004 OCT 26; 63 (8): 1376-1384	66	66	24	37
1015	15005 Auluck PK, Meulener MC, Bonini NM Mechanisms of suppression of alpha-synuclein neurotoxicity by geldanamycin in Drosophila JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JAN 28; 280 (4): 2873-2878	66	87	28	42
1016	15428 Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, et al. Amyloid beta protein immunotherapy neutralizes A beta oligomers that disrupt synaptic plasticity in vivo NATURE MEDICINE. 2005 MAY; 11 (5): 556-561	66	194	5	30
1017	15496 Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, et al. Frontotemporal lobar degeneration - Demographic characteristics of 353 patients ARCHIVES OF NEUROLOGY. 2005 JUN; 62 (6): 925-930	66	86	16	36
1018	16144 Pittman AM, Myers AJ, Abou-Sleiman P, Fung HC, Kaleem M, et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration JOURNAL OF MEDICAL GENETICS. 2005 NOV; 42 (11): 837-846	66	74	24	36
1019	16166 LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ Dopamine covalently modifies and functionally inactivates parkin NATURE MEDICINE. 2005 NOV; 11 (11): 1214-1221	66	146	20	50
1020	16207 Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L) JOURNAL OF NEUROSCIENCE. 2005 NOV 16; 25 (46): 10637-10647	66	87	23	34
#	Date / Author / Journal	LCS	GCS	LCR	CR
1021	18537 Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2007 FEB; 66 (2): 142-151	66	70	30	41
1022	4865 Ginsberg SD, Crino PB, Lee VMY, Eberwine JH, Trojanowski JQ Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques ANNALS OF NEUROLOGY. 1997 FEB; 41 (2): 200-209	65	65	12	51
1023	5022 Xu HX, Sweeney D, Wang R, Thinakaran G, Lo ACY, et al. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1997 APR 15; 94 (8): 3748-3752	65	163	3	32
1024	7475 Dickson DW, Lin WL, Liu WK, Yen SH Multiple system atrophy: A sporadic synucleinopathy BRAIN PATHOLOGY. 1999 OCT; 9 (4): 721-732	65	91	32	84
1025	9627 Woulfe J, Kertesz A, Munoz DG Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions ACTA NEUROPATHOLOGICA. 2001 JUL; 102 (1): 94-102	65	73	11	38
1026	10315 Rademakers R, Cruts M, Dermaut B, Sleegers K, Rosso SM, et al. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval MOLECULAR PSYCHIATRY. 2002; 7 (10): 1064-1074	65	74	19	47
1027	11490 Fath T, Eidenmuller J, Brandt R Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease JOURNAL OF NEUROSCIENCE. 2002 NOV 15; 22 (22): 9733-9741	65	82	30	53
1028	12179 Taylor JP, Tanaka F, Robitschek J, Sandoval CM, Taye A, et al. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein HUMAN MOLECULAR GENETICS. 2003 APR 1; 12 (7): 749-757	65	184	9	28
1029	12360 de Silva R, Lashley T, Gibb G, Hanger D, Hope A, et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 JUN; 29 (3): 288-302	65	81	33	39
1030	12919 Stefani M, Dobson CM Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution JOURNAL OF MOLECULAR MEDICINE-JMM. 2003 NOV; 81 (11): 678-699	65	491	37	200
#	Date / Author / Journal	LCS	GCS	LCR	CR
1031	13651 Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, et al. Oxidative modifications and down-regulation of ubiquitin carboxyl- terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 MAR 26; 279 (13): 13256-13264	65	173	15	40
1032	14468 Choi W, Zibaee S, Jakes R, Serpell LC, Davletov B, et al. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein FEBS LETTERS. 2004 OCT 22; 576 (3): 363-368	65	69	45	59
1033	14594 Sung S, Yang HX, Uryu K, Lee EB, Zhao L, et al. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not ap precursor protein metabolism in a model of Alzheimer's disease AMERICAN JOURNAL OF PATHOLOGY. 2004 DEC; 165 (6): 2197-2206	65	65	7	42
1034	14997 Dedmon MM, Lindorff-Larsen K, Christodoulou J, Vendruscolo M, Dobson CM Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2005 JAN 19; 127 (2): 476-477	65	140	9	22
1035	15237 Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, et al. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration NEURON. 2005 MAR 24; 45 (6): 847-859	65	65	20	43
1036	15578 Smith WW, Margolis RL, Li XJ, Troncoso JC, Lee MK, et al. alpha-Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells JOURNAL OF NEUROSCIENCE. 2005 JUN 8; 25 (23): 5544-5552	65	72	39	53
1037	17881 Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AMT, Varma A, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia BRAIN. 2006 NOV; 129: 3091-3102	65	73	21	52
1038	18678 Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2007 MAR; 66 (3): 177-183	65	65	21	29
1039	20808 Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods JOURNAL OF MAGNETIC RESONANCE IMAGING. 2008 APR; 27 (4): 685-691	65	128	2	21
1040	175 Trojanowski JQ, KLEINMAN GM, PROPPE KH MALIGNANT-TUMORS OF NERVE SHEATH ORIGIN CANCER. 1980; 46 (5): 1202-1212	64	64	0	14
#	Date / Author / Journal	LCS	GCS	LCR	CR
1041	1417 HEIER LA, BAUER CJ, SCHWARTZ L, ZIMMERMAN RD, MORGELLO S, et al. LARGE VIRCHOW-ROBIN SPACES - MR-CLINICAL CORRELATION AMERICAN JOURNAL OF NEURORADIOLOGY. 1989 SEP-OCT; 10 (5): 929-936	64	165	1	9
1042	1935 HANGER DP, BRION JP, GALLO JM, CAIRNS NJ, LUTHERT PJ, et al. TAU IN ALZHEIMERS-DISEASE AND DOWNS-SYNDROME IS INSOLUBLE AND ABNORMALLY PHOSPHORYLATED BIOCHEMICAL JOURNAL. 1991 APR 1; 275: 99-104	64	88	2	33
1043	2685 BRANDT R, LEE G FUNCTIONAL-ORGANIZATION OF MICROTUBULE-ASSOCIATED PROTEIN-TAU - IDENTIFICATION OF REGIONS WHICH AFFECT MICROTUBULE GROWTH, NUCLEATION, AND BUNDLE FORMATION INVITRO JOURNAL OF BIOLOGICAL CHEMISTRY. 1993 FEB 15; 268 (5): 3414-3419	64	122	12	58
1044	3054 LIPPA CF, SMITH TW, SWEARER JM ALZHEIMERS-DISEASE AND LEWY BODY DISEASE - A COMPARATIVE CLINICOPATHOLOGICAL STUDY ANNALS OF NEUROLOGY. 1994 JAN; 35 (1): 81-88	64	134	3	59
1045	3161 GONG CX, GRUNDKEIQBAL I, DAMUNI Z, IQBAL K DEPHOSPHORYLATION OF MICROTUBULE-ASSOCIATED PROTEIN-TAU BY PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2C AND ITS IMPLICATION IN ALZHEIMER- DISEASE FEBS LETTERS. 1994 MAR 14; 341 (1): 94-98	64	80	15	33
1046	3940 Pant HC, Veeranna Neurofilament phosphorylation BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE. 1995 SEP-OCT; 73 (9-10): 575-592	64	127	25	84
1047	5085 McShea A, Harris PLR, Webster KR, Wahl AF, Smith MA Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease AMERICAN JOURNAL OF PATHOLOGY. 1997 JUN; 150 (6): 1933-1939	64	226	15	52
1048	5626 Julien JP, Mushynski WE Neurofilaments in health and disease PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 61. 1998; 61: 1-23	64	155	55	125
1049	6093 Shoji M, Matsubara E, Kanai M, Watanabe M, Nakamura T, et al. Combination assay of CSF Tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease JOURNAL OF THE NEUROLOGICAL SCIENCES. 1998 JUN 30; 158 (2): 134-140	64	106	3	21
1050	6323 Sengupta A, Kabat J, Novak M, Wu QL, Grundke-Iqbal I, et al. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 1998 SEP 15; 357 (2): 299-309	64	89	23	38
#	Date / Author / Journal	LCS	GCS	LCR	CR
1051	6851 Surguchov A, Surgucheva I, Solessio E, Baehr W Synoretin - A new protein belonging to the synuclein family MOLECULAR AND CELLULAR NEUROSCIENCE. 1999 FEB; 13 (2): 95-103	64	68	9	35
1052	7036 Braak H, Sandmann-Keil D, Gai WP, Braak E Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry NEUROSCIENCE LETTERS. 1999 APR 9; 265 (1): 67-69	64	72	8	16
1053	7365 Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, et al. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation NEUROREPORT. 1999 AUG 2; 10 (11): 2411-2415	64	156	10	19
1054	8887 Pickering-Brown S, Baker M, Yen SH, Liu WK, Hasegawa M, et al. Pick's disease is associated with mutations in the tau gene ANNALS OF NEUROLOGY. 2000 DEC; 48 (6): 859-867	64	70	14	20
1055	9504 Sjogren M, Davidsson P, Tullberg M, Minthon L, Wallin A, et al. Both total and phosphorylated tau are increased in Alzheimer's disease JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2001 MAY; 70 (5): 624-630	64	97	29	53
1056	9544 Turnbull S, Tabner BJ, El-Agnaf OMA, Moore S, Davies Y, et al. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro FREE RADICAL BIOLOGY AND MEDICINE. 2001 MAY 15; 30 (10): 1163-1170	64	99	18	37
1057	10167 Bussell R, Eliezer D Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 DEC 7; 276 (49): 45996-46003	64	95	25	55
1058	11116 Higuchi M, Ishihara T, Zhang B, Hong M, Andreadis A, et al. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration NEURON. 2002 AUG 1; 35 (3): 433-446	64	64	48	65
1059	11433 McLean PJ, Kawamata H, Shariff S, Hewett J, Sharma N, et al. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation JOURNAL OF NEUROCHEMISTRY. 2002 NOV; 83 (4): 846-854	64	115	15	28
1060	12568 Ono M, Wilson A, Nobrega J, Westaway D, Verhoeff P, et al. C-11-labeled stilbene derivatives as A beta-aggregate-specific PET imaging agents for Alzheimer's disease NUCLEAR MEDICINE AND BIOLOGY. 2003 AUG; 30 (6): 565-571	64	95	9	33
#	Date / Author / Journal	LCS	GCS	LCR	CR
1061	12631 Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, LightFoot R, et al. Nitration of tau protein is linked to neurodegeneration in tauopathies AMERICAN JOURNAL OF PATHOLOGY. 2003 SEP; 163 (3): 1021-1031	64	64	36	57
1062	13799 Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress DEVELOPMENT. 2004 MAY; 131 (9): 2183-2194	64	147	29	69
1063	15057 Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, et al. Extensive involvement of autophagy in Alzheimer disease: An immuno- electron microscopy study JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 FEB; 64 (2): 113-122	64	186	12	77
1064	15200 Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, et al. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 MAR 4; 280 (9): 7614-7623	64	112	25	53
1065	16678 Khlistunova I, Biernat J, Wang YP, Pickhardt M, von Bergen M, et al. Inducible expression of tau repeat domain in cell models of tauopathy - Aggregation is toxic to cells but can be reversed by inhibitor drugs JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 JAN 13; 281 (2): 1205-1214	64	79	37	57
1066	17713 Hardy J, Cai HB, Cookson MR, Gwinn-Hardy K, Singleton A Genetics of Parkinson's disease and parkinsonism ANNALS OF NEUROLOGY. 2006 OCT; 60 (4): 389-398	64	131	42	86
1067	17976 Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, et al. alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis JOURNAL OF NEUROSCIENCE. 2006 NOV 15; 26 (46): 11915-11922	64	77	28	48
1068	18590 Kramer ML, Schulz-Schaeffer WJ Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies JOURNAL OF NEUROSCIENCE. 2007 FEB 7; 27 (6): 1405-1410	64	76	13	28
1069	19212 Kwong LK, Neumann M, Sampathu DM, Lee VMY, Trojanowski JQ TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 63-70	64	64	29	55
1070	21147 Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, et al. Concomitant TAR-DNA-binding in Alzheimer disease and protein 43 pathology is present corticobasal degeneration but not in other tauopathies JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 JUN; 67 (6): 555-564	64	64	31	34
#	Date / Author / Journal	LCS	GCS	LCR	CR
1071	21596 Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, et al. Novel Mutations in TARDBP(TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis PLOS GENETICS. 2008 SEP; 4 (9): Art. No. e1000193	64	79	22	40
1072	30 OGREN M, HENDRICKSON A PATHWAYS BETWEEN STRIATE CORTEX AND SUBCORTICAL REGIONS IN MACACA- MULATTA AND SAIMIRI-SCIUREUS - EVIDENCE FOR A RECIPROCAL PULVINAR CONNECTION EXPERIMENTAL NEUROLOGY. 1976; 53 (3): 780-800	63	140	1	50
1073	324 Trojanowski JQ, Lee VMY, PILLSBURY N, LEE S NEURONAL ORIGIN OF HUMAN ESTHESIONEUROBLASTOMA DEMONSTRATED WITH ANTI-NEUROFILAMENT MONOCLONAL-ANTIBODIES NEW ENGLAND JOURNAL OF MEDICINE. 1982; 307 (3): 159-161	63	63	1	12
1074	851 BURGER PC, GRAHMANN FC, BLIESTLE A, KLEIHUES P DIFFERENTIATION IN THE MEDULLOBLASTOMA - A HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY ACTA NEUROPATHOLOGICA. 1987; 73 (2): 115-123	63	111	3	33
1075	1623 SIHAG RK, NIXON RA PHOSPHORYLATION OF THE AMINO-TERMINAL HEAD DOMAIN OF THE MIDDLE MOLECULAR MASS 145-KDA SUBUNIT OF NEUROFILAMENTS - EVIDENCE FOR REGULATION BY 2ND MESSENGER-DEPENDENT PROTEIN-KINASES JOURNAL OF BIOLOGICAL CHEMISTRY. 1990 MAR 5; 265 (7): 4166-4171	63	108	9	42
1076	1648 BIGNER SH, FRIEDMAN HS, VOGELSTEIN B, OAKES WJ, BIGNER DD AMPLIFICATION OF THE C-MYC GENE IN HUMAN MEDULLOBLASTOMA CELL-LINES AND XENOGRAFTS CANCER RESEARCH. 1990 APR 15; 50 (8): 2347-2350	63	133	4	28
1077	2219 YAMADA T, MCGEER PL, MCGEER EG APPEARANCE OF PAIRED NUCLEATED, TAU-POSITIVE GLIA IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY BRAIN-TISSUE NEUROSCIENCE LETTERS. 1992 JAN 20; 135 (1): 99-102	63	131	1	15
1078	2671 LU Q, WOOD JG FUNCTIONAL-STUDIES OF ALZHEIMERS-DISEASE TAU PROTEIN JOURNAL OF NEUROSCIENCE. 1993 FEB; 13 (2): 508-515	63	77	8	43
1079	3589 DAHLSTRAND J, LARDELLI M, LENDAHL U NESTIN MESSENGER-RNA EXPRESSION CORRELATES WITH THE CENTRAL-NERVOUS- SYSTEM PROGENITOR-CELL STATE IN MANY, BUT NOT ALL, REGIONS OF DEVELOPING CENTRAL-NERVOUS-SYSTEM DEVELOPMENTAL BRAIN RESEARCH. 1995 JAN 14; 84 (1): 109-129	63	163	12	63
1080	3852 FEANY MB, KSIEZAKREDING H, LIU WK, VINCENT I, YEN SHC, et al. EPITOPE EXPRESSION AND HYPERPHOSPHORYLATION OF TAU-PROTEIN IN CORTICOBASAL DEGENERATION - DIFFERENTIATION FROM PROGRESSIVE SUPRANUCLEAR PALSY ACTA NEUROPATHOLOGICA. 1995 JUL; 90 (1): 37-43	63	93	14	40
#	Date / Author / Journal	LCS	GCS	LCR	CR
1081	5995 Elder GA, Friedrich VL, Bosco P, Kang CH, Gourov A, et al. Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content JOURNAL OF CELL BIOLOGY. 1998 MAY 4; 141 (3): 727-739	63	102	16	45
1082	6392 Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, et al. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA NATURE GENETICS. 1998 OCT; 20 (2): 198-202	63	254	3	30
1083	6696 Saporta S, Borlongan CV, Sanberg PR Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery NEUROSCIENCE. 1999; 91 (2): 519-525	63	79	10	40
1084	8312 Ancolio K, da Costa CA, Ueda K, Checler F alpha-Synuclein and the Parkinson's disease-related mutant Ala53Thr- alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells NEUROSCIENCE LETTERS. 2000 MAY 12; 285 (2): 79-82	63	69	9	21
1085	9961 Kins S, Crameri A, Evans DRH, Hemmings BA, Nitsch RM, et al. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 OCT 12; 276 (41): 38193-38200	63	85	48	79
1086	10148 Tanemura K, Akagi T, Murayama M, Kikuchi N, Murayama O, et al. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau NEUROBIOLOGY OF DISEASE. 2001 DEC; 8 (6): 1036-1045	63	71	20	24
1087	10727 Uversky VN, Yamin G, Souillac PO, Goers J, Glaser CB, et al. Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro FEBS LETTERS. 2002 APR 24; 517 (1-3): 239-244	63	88	21	55
1088	11905 Krishnan S, Chi EY, Wood SJ, Kendrick BS, Li C, et al. Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis BIOCHEMISTRY. 2003 JAN 28; 42 (3): 829-837	63	88	28	60
1089	12498 Goers J, Manning-Bog AB, McCormack AL, Millett IS, Doniach S, et al. Nuclear localization of alpha-synuclein and its interaction with histones BIOCHEMISTRY. 2003 JUL 22; 42 (28): 8465-8471	63	76	19	33
1090	14013 Zhu M, Rajamani S, Kaylor J, Han S, Zhou FM, et al. The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 JUN 25; 279 (26): 26846-26857	63	99	16	41
#	Date / Author / Journal	LCS	GCS	LCR	CR
1091	16873 de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, et al. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment NEUROBIOLOGY OF AGING. 2006 MAR; 27 (3): 394-401	63	97	18	38
1092	17240 Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, et al. Novel ubiquitin neuropathology in frontotemporal dementia with valosin- containing protein gene mutations JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2006 JUN; 65 (6): 571-581	63	76	20	60
1093	18668 Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins JOURNAL OF CLINICAL INVESTIGATION. 2007 MAR; 117 (3): 648-658	63	110	20	51
1094	20273 Geser F, Winton MJ, Kwong LK, Xu Y, Xie SX, et al. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam ACTA NEUROPATHOLOGICA. 2008 JAN; 115 (1): 133-145	63	63	21	38
1095	1329 TALAMO BR, RUDEL RA, KOSIK KS, LEE VMY, NEFF S, et al. PATHOLOGICAL-CHANGES IN OLFACTORY NEURONS IN PATIENTS WITH ALZHEIMERS- DISEASE NATURE. 1989 FEB 23; 337 (6209): 736-739	62	182	7	31
1096	2578 ISHIGURO K, OMORI A, TAKAMATSU M, SATO K, ARIOKA M, et al. PHOSPHORYLATION SITES ON TAU BY TAU PROTEIN KINASE-I, A BOVINE DERIVED KINASE GENERATING AN EPITOPE OF PAIRED HELICAL FILAMENTS NEUROSCIENCE LETTERS. 1992 DEC 14; 148 (1-2): 202-206	62	104	13	25
1097	2980 MANDELKOW EM, MANDELKOW E TAU AS A MARKER FOR ALZHEIMERS-DISEASE TRENDS IN BIOCHEMICAL SCIENCES. 1993 DEC; 18 (12): 480-483	62	112	25	46
1098	4252 Gritti A, Parati EA, Cova L, Frolichsthal P, Galii R, et al. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor JOURNAL OF NEUROSCIENCE. 1996 FEB 1; 16 (3): 1091-1100	62	643	1	55
1099	4921 Trojanowski JQ, Kleppner SR, Hartley RS, Miyazono M, Fraser NW, et al. Transfectable and transplantable postmitotic human neurons: A potential ''platform'' for gene therapy of nervous system diseases EXPERIMENTAL NEUROLOGY. 1997 MAR; 144 (1): 92-97	62	62	23	36
1100	5084 Crino PB, Trojanowski JQ, Eberwine J Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity ACTA NEUROPATHOLOGICA. 1997 JUN; 93 (6): 619-627	62	62	6	28

Date / Author / Journal

LCS

GCS

LCR

1001

17 JACOBSON S, Trojanowski JQ

AMYGDALOID PROJECTIONS TO PREFRONTAL GRANULAR CORTEX IN RHESUS-MONKEY DEMONSTRATED WITH HORSERADISH-PEROXIDASE

BRAIN RESEARCH. 1975; 100 (1): 132-139

1002

2802 RODER HM, EDEN PA, INGRAM VM

BRAIN PROTEIN-KINASE PK40(ERK) CONVERTS TAU INTO A PHF-LIKE FORM AS FOUND IN ALZHEIMERS-DISEASE

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1993 JUN 15; 193 (2): 639-647

108

1003

3678 CHOILUNDBERG DL, BOHN MC

ONTOGENY AND DISTRIBUTION OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) MESSENGER-RNA IN RAT

DEVELOPMENTAL BRAIN RESEARCH. 1995 MAR 16; 85 (1): 80-88

172

1004

4320 BueeScherrer V, Hof PR, Buee L, Leveugle B, Vermersch P, et al.

Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease

ACTA NEUROPATHOLOGICA. 1996 APR; 91 (4): 351-359

1005

5193 Liu XZ, Xu XM, Hu R, Du C, Zhang SX, et al.

Neuronal and glial apoptosis after traumatic spinal cord injury

JOURNAL OF NEUROSCIENCE. 1997 JUL 15; 17 (14): 5395-5406

396

1006

5560 Price DL, Tanzi RE, Borchelt DR, Sisodia SS

Alzheimer's disease: Genetic studies and transgenic models

ANNUAL REVIEW OF GENETICS. 1998; 32: 461-493

231

226

1007

5877 Vaughan JR, Farrer MJ, Wszolek ZK, Gasser T, Durr A, et al.

Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations

HUMAN MOLECULAR GENETICS. 1998 APR; 7 (4): 751-753

1008

6324 Canu N, Dus L, Barbato C, Ciotti MT, Brancolini C, et al.

Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis

JOURNAL OF NEUROSCIENCE. 1998 SEP 15; 18 (18): 7061-7074

140

1009

6867 Kim JYH, Sutton ME, Lu DJ, Cho TA, Goumnerova LC, et al.

Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas

CANCER RESEARCH. 1999 FEB 1; 59 (3): 711-719

1010

10919 Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, et al.

Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters

JOURNAL OF NEUROSCIENCE RESEARCH. 2002 JUN 1; 68 (5): 568-578

Date / Author / Journal

LCS

GCS

LCR

1011

13178 Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, et al.

Interactions among alpha-synuclein, dopamine, and biomembranes - Some clues for understanding neurodegeneration in Parkinson's disease

JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 23 (1-2): 23-33

1012

13495 Lee HJ, Khoshaghideh F, Patel S, Lee SJ

Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway

JOURNAL OF NEUROSCIENCE. 2004 FEB 25; 24 (8): 1888-1896

1013

14226 Alonso AD, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K

Promotion of hyperphosphorylation by frontotemporal dementia tau mutations

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 AUG 13; 279 (33): 34873-34881

1014

14472 Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, et al.

Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease

NEUROLOGY. 2004 OCT 26; 63 (8): 1376-1384

1015

15005 Auluck PK, Meulener MC, Bonini NM

Mechanisms of suppression of alpha-synuclein neurotoxicity by geldanamycin in Drosophila

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JAN 28; 280 (4): 2873-2878

1016

15428 Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, et al.

Amyloid beta protein immunotherapy neutralizes A beta oligomers that disrupt synaptic plasticity in vivo

NATURE MEDICINE. 2005 MAY; 11 (5): 556-561

194

1017

15496 Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, et al.

Frontotemporal lobar degeneration - Demographic characteristics of 353 patients

ARCHIVES OF NEUROLOGY. 2005 JUN; 62 (6): 925-930

1018

16144 Pittman AM, Myers AJ, Abou-Sleiman P, Fung HC, Kaleem M, et al.

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration

JOURNAL OF MEDICAL GENETICS. 2005 NOV; 42 (11): 837-846

1019

16166 LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ

Dopamine covalently modifies and functionally inactivates parkin

NATURE MEDICINE. 2005 NOV; 11 (11): 1214-1221

146

1020

16207 Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, et al.

Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)

JOURNAL OF NEUROSCIENCE. 2005 NOV 16; 25 (46): 10637-10647

Date / Author / Journal

LCS

GCS

LCR

1021

18537 Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, et al.

Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2007 FEB; 66 (2): 142-151

1022

4865 Ginsberg SD, Crino PB, Lee VMY, Eberwine JH, Trojanowski JQ

Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques

ANNALS OF NEUROLOGY. 1997 FEB; 41 (2): 200-209

1023

5022 Xu HX, Sweeney D, Wang R, Thinakaran G, Lo ACY, et al.

Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1997 APR 15; 94 (8): 3748-3752

163

1024

7475 Dickson DW, Lin WL, Liu WK, Yen SH

Multiple system atrophy: A sporadic synucleinopathy

BRAIN PATHOLOGY. 1999 OCT; 9 (4): 721-732

1025

9627 Woulfe J, Kertesz A, Munoz DG

Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions

ACTA NEUROPATHOLOGICA. 2001 JUL; 102 (1): 94-102

1026

10315 Rademakers R, Cruts M, Dermaut B, Sleegers K, Rosso SM, et al.

Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval

MOLECULAR PSYCHIATRY. 2002; 7 (10): 1064-1074

1027

11490 Fath T, Eidenmuller J, Brandt R

Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease

JOURNAL OF NEUROSCIENCE. 2002 NOV 15; 22 (22): 9733-9741

1028

12179 Taylor JP, Tanaka F, Robitschek J, Sandoval CM, Taye A, et al.

Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein

HUMAN MOLECULAR GENETICS. 2003 APR 1; 12 (7): 749-757

184

1029

12360 de Silva R, Lashley T, Gibb G, Hanger D, Hope A, et al.

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 JUN; 29 (3): 288-302

1030

12919 Stefani M, Dobson CM

Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

JOURNAL OF MOLECULAR MEDICINE-JMM. 2003 NOV; 81 (11): 678-699

491

200

Date / Author / Journal

LCS

GCS

LCR

1031

13651 Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, et al.

Oxidative modifications and down-regulation of ubiquitin carboxyl- terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 MAR 26; 279 (13): 13256-13264

173

1032

14468 Choi W, Zibaee S, Jakes R, Serpell LC, Davletov B, et al.

Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein

FEBS LETTERS. 2004 OCT 22; 576 (3): 363-368

1033

14594 Sung S, Yang HX, Uryu K, Lee EB, Zhao L, et al.

Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not ap precursor protein metabolism in a model of Alzheimer's disease

AMERICAN JOURNAL OF PATHOLOGY. 2004 DEC; 165 (6): 2197-2206

1034

14997 Dedmon MM, Lindorff-Larsen K, Christodoulou J, Vendruscolo M, Dobson CM

Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2005 JAN 19; 127 (2): 476-477

140

1035

15237 Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, et al.

Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration

NEURON. 2005 MAR 24; 45 (6): 847-859

1036

15578 Smith WW, Margolis RL, Li XJ, Troncoso JC, Lee MK, et al.

alpha-Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells

JOURNAL OF NEUROSCIENCE. 2005 JUN 8; 25 (23): 5544-5552

1037

17881 Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AMT, Varma A, et al.

Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia

BRAIN. 2006 NOV; 129: 3091-3102

1038

18678 Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, et al.

TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2007 MAR; 66 (3): 177-183

1039

20808 Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, et al.

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods

JOURNAL OF MAGNETIC RESONANCE IMAGING. 2008 APR; 27 (4): 685-691

128

1040

175 Trojanowski JQ, KLEINMAN GM, PROPPE KH

MALIGNANT-TUMORS OF NERVE SHEATH ORIGIN

CANCER. 1980; 46 (5): 1202-1212

Date / Author / Journal

LCS

GCS

LCR

1041

1417 HEIER LA, BAUER CJ, SCHWARTZ L, ZIMMERMAN RD, MORGELLO S, et al.

LARGE VIRCHOW-ROBIN SPACES - MR-CLINICAL CORRELATION

AMERICAN JOURNAL OF NEURORADIOLOGY. 1989 SEP-OCT; 10 (5): 929-936

165

1042

1935 HANGER DP, BRION JP, GALLO JM, CAIRNS NJ, LUTHERT PJ, et al.

TAU IN ALZHEIMERS-DISEASE AND DOWNS-SYNDROME IS INSOLUBLE AND ABNORMALLY PHOSPHORYLATED

BIOCHEMICAL JOURNAL. 1991 APR 1; 275: 99-104

1043

2685 BRANDT R, LEE G

FUNCTIONAL-ORGANIZATION OF MICROTUBULE-ASSOCIATED PROTEIN-TAU - IDENTIFICATION OF REGIONS WHICH AFFECT MICROTUBULE GROWTH, NUCLEATION, AND BUNDLE FORMATION INVITRO

JOURNAL OF BIOLOGICAL CHEMISTRY. 1993 FEB 15; 268 (5): 3414-3419

122

1044

3054 LIPPA CF, SMITH TW, SWEARER JM

ALZHEIMERS-DISEASE AND LEWY BODY DISEASE - A COMPARATIVE CLINICOPATHOLOGICAL STUDY

ANNALS OF NEUROLOGY. 1994 JAN; 35 (1): 81-88

134

1045

3161 GONG CX, GRUNDKEIQBAL I, DAMUNI Z, IQBAL K

DEPHOSPHORYLATION OF MICROTUBULE-ASSOCIATED PROTEIN-TAU BY PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2C AND ITS IMPLICATION IN ALZHEIMER- DISEASE

FEBS LETTERS. 1994 MAR 14; 341 (1): 94-98

1046

3940 Pant HC, Veeranna

Neurofilament phosphorylation

BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE. 1995 SEP-OCT; 73 (9-10): 575-592

127

1047

5085 McShea A, Harris PLR, Webster KR, Wahl AF, Smith MA

Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease

AMERICAN JOURNAL OF PATHOLOGY. 1997 JUN; 150 (6): 1933-1939

226

1048

5626 Julien JP, Mushynski WE

Neurofilaments in health and disease

PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 61. 1998; 61: 1-23

155

125

1049

6093 Shoji M, Matsubara E, Kanai M, Watanabe M, Nakamura T, et al.

Combination assay of CSF Tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease

JOURNAL OF THE NEUROLOGICAL SCIENCES. 1998 JUN 30; 158 (2): 134-140

106

1050

6323 Sengupta A, Kabat J, Novak M, Wu QL, Grundke-Iqbal I, et al.

Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 1998 SEP 15; 357 (2): 299-309

Date / Author / Journal

LCS

GCS

LCR

1051

6851 Surguchov A, Surgucheva I, Solessio E, Baehr W

Synoretin - A new protein belonging to the synuclein family

MOLECULAR AND CELLULAR NEUROSCIENCE. 1999 FEB; 13 (2): 95-103

1052

7036 Braak H, Sandmann-Keil D, Gai WP, Braak E

Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry

NEUROSCIENCE LETTERS. 1999 APR 9; 265 (1): 67-69

1053

7365 Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, et al.

Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation

NEUROREPORT. 1999 AUG 2; 10 (11): 2411-2415

156

1054

8887 Pickering-Brown S, Baker M, Yen SH, Liu WK, Hasegawa M, et al.

Pick's disease is associated with mutations in the tau gene

ANNALS OF NEUROLOGY. 2000 DEC; 48 (6): 859-867

1055

9504 Sjogren M, Davidsson P, Tullberg M, Minthon L, Wallin A, et al.

Both total and phosphorylated tau are increased in Alzheimer's disease

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2001 MAY; 70 (5): 624-630

1056

9544 Turnbull S, Tabner BJ, El-Agnaf OMA, Moore S, Davies Y, et al.

alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro

FREE RADICAL BIOLOGY AND MEDICINE. 2001 MAY 15; 30 (10): 1163-1170

1057

10167 Bussell R, Eliezer D

Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein

JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 DEC 7; 276 (49): 45996-46003

1058

11116 Higuchi M, Ishihara T, Zhang B, Hong M, Andreadis A, et al.

Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration

NEURON. 2002 AUG 1; 35 (3): 433-446

1059

11433 McLean PJ, Kawamata H, Shariff S, Hewett J, Sharma N, et al.

TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation

JOURNAL OF NEUROCHEMISTRY. 2002 NOV; 83 (4): 846-854

115

1060

12568 Ono M, Wilson A, Nobrega J, Westaway D, Verhoeff P, et al.

C-11-labeled stilbene derivatives as A beta-aggregate-specific PET imaging agents for Alzheimer's disease

NUCLEAR MEDICINE AND BIOLOGY. 2003 AUG; 30 (6): 565-571

Date / Author / Journal

LCS

GCS

LCR

1061

12631 Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, LightFoot R, et al.

Nitration of tau protein is linked to neurodegeneration in tauopathies

AMERICAN JOURNAL OF PATHOLOGY. 2003 SEP; 163 (3): 1021-1031

1062

13799 Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, et al.

Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress

DEVELOPMENT. 2004 MAY; 131 (9): 2183-2194

147

1063

15057 Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, et al.

Extensive involvement of autophagy in Alzheimer disease: An immuno- electron microscopy study

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 FEB; 64 (2): 113-122

186

1064

15200 Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, et al.

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 MAR 4; 280 (9): 7614-7623

112

1065

16678 Khlistunova I, Biernat J, Wang YP, Pickhardt M, von Bergen M, et al.

Inducible expression of tau repeat domain in cell models of tauopathy - Aggregation is toxic to cells but can be reversed by inhibitor drugs

JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 JAN 13; 281 (2): 1205-1214

1066

17713 Hardy J, Cai HB, Cookson MR, Gwinn-Hardy K, Singleton A

Genetics of Parkinson's disease and parkinsonism

ANNALS OF NEUROLOGY. 2006 OCT; 60 (4): 389-398

131

1067

17976 Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, et al.

alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis

JOURNAL OF NEUROSCIENCE. 2006 NOV 15; 26 (46): 11915-11922

1068

18590 Kramer ML, Schulz-Schaeffer WJ

Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies

JOURNAL OF NEUROSCIENCE. 2007 FEB 7; 27 (6): 1405-1410

1069

19212 Kwong LK, Neumann M, Sampathu DM, Lee VMY, Trojanowski JQ

TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease

ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 63-70

1070

21147 Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, et al.

Concomitant TAR-DNA-binding in Alzheimer disease and protein 43 pathology is present corticobasal degeneration but not in other tauopathies

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 JUN; 67 (6): 555-564

Date / Author / Journal

LCS

GCS

LCR

1071

21596 Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, et al.

Novel Mutations in TARDBP(TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis

PLOS GENETICS. 2008 SEP; 4 (9): Art. No. e1000193

1072

30 OGREN M, HENDRICKSON A

PATHWAYS BETWEEN STRIATE CORTEX AND SUBCORTICAL REGIONS IN MACACA- MULATTA AND SAIMIRI-SCIUREUS - EVIDENCE FOR A RECIPROCAL PULVINAR CONNECTION

EXPERIMENTAL NEUROLOGY. 1976; 53 (3): 780-800

140

1073

324 Trojanowski JQ, Lee VMY, PILLSBURY N, LEE S

NEURONAL ORIGIN OF HUMAN ESTHESIONEUROBLASTOMA DEMONSTRATED WITH ANTI-NEUROFILAMENT MONOCLONAL-ANTIBODIES

NEW ENGLAND JOURNAL OF MEDICINE. 1982; 307 (3): 159-161

1074

851 BURGER PC, GRAHMANN FC, BLIESTLE A, KLEIHUES P

DIFFERENTIATION IN THE MEDULLOBLASTOMA - A HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY

ACTA NEUROPATHOLOGICA. 1987; 73 (2): 115-123

111

1075

1623 SIHAG RK, NIXON RA

PHOSPHORYLATION OF THE AMINO-TERMINAL HEAD DOMAIN OF THE MIDDLE MOLECULAR MASS 145-KDA SUBUNIT OF NEUROFILAMENTS - EVIDENCE FOR REGULATION BY 2ND MESSENGER-DEPENDENT PROTEIN-KINASES

JOURNAL OF BIOLOGICAL CHEMISTRY. 1990 MAR 5; 265 (7): 4166-4171

108

1076

1648 BIGNER SH, FRIEDMAN HS, VOGELSTEIN B, OAKES WJ, BIGNER DD

AMPLIFICATION OF THE C-MYC GENE IN HUMAN MEDULLOBLASTOMA CELL-LINES AND XENOGRAFTS

CANCER RESEARCH. 1990 APR 15; 50 (8): 2347-2350

133

1077

2219 YAMADA T, MCGEER PL, MCGEER EG

APPEARANCE OF PAIRED NUCLEATED, TAU-POSITIVE GLIA IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY BRAIN-TISSUE

NEUROSCIENCE LETTERS. 1992 JAN 20; 135 (1): 99-102

131

1078

2671 LU Q, WOOD JG

FUNCTIONAL-STUDIES OF ALZHEIMERS-DISEASE TAU PROTEIN

JOURNAL OF NEUROSCIENCE. 1993 FEB; 13 (2): 508-515

1079

3589 DAHLSTRAND J, LARDELLI M, LENDAHL U

NESTIN MESSENGER-RNA EXPRESSION CORRELATES WITH THE CENTRAL-NERVOUS- SYSTEM PROGENITOR-CELL STATE IN MANY, BUT NOT ALL, REGIONS OF DEVELOPING CENTRAL-NERVOUS-SYSTEM

DEVELOPMENTAL BRAIN RESEARCH. 1995 JAN 14; 84 (1): 109-129

163

1080

3852 FEANY MB, KSIEZAKREDING H, LIU WK, VINCENT I, YEN SHC, et al.

EPITOPE EXPRESSION AND HYPERPHOSPHORYLATION OF TAU-PROTEIN IN CORTICOBASAL DEGENERATION - DIFFERENTIATION FROM PROGRESSIVE SUPRANUCLEAR PALSY

ACTA NEUROPATHOLOGICA. 1995 JUL; 90 (1): 37-43

Date / Author / Journal

LCS

GCS

LCR

1081

5995 Elder GA, Friedrich VL, Bosco P, Kang CH, Gourov A, et al.

Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content

JOURNAL OF CELL BIOLOGY. 1998 MAY 4; 141 (3): 727-739

102

1082

6392 Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, et al.

Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA

NATURE GENETICS. 1998 OCT; 20 (2): 198-202

254

1083

6696 Saporta S, Borlongan CV, Sanberg PR

Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery

NEUROSCIENCE. 1999; 91 (2): 519-525

1084

8312 Ancolio K, da Costa CA, Ueda K, Checler F

alpha-Synuclein and the Parkinson's disease-related mutant Ala53Thr- alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells

NEUROSCIENCE LETTERS. 2000 MAY 12; 285 (2): 79-82

1085

9961 Kins S, Crameri A, Evans DRH, Hemmings BA, Nitsch RM, et al.

Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice

JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 OCT 12; 276 (41): 38193-38200

1086

10148 Tanemura K, Akagi T, Murayama M, Kikuchi N, Murayama O, et al.

Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau

NEUROBIOLOGY OF DISEASE. 2001 DEC; 8 (6): 1036-1045

1087

10727 Uversky VN, Yamin G, Souillac PO, Goers J, Glaser CB, et al.

Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro

FEBS LETTERS. 2002 APR 24; 517 (1-3): 239-244

1088

11905 Krishnan S, Chi EY, Wood SJ, Kendrick BS, Li C, et al.

Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis

BIOCHEMISTRY. 2003 JAN 28; 42 (3): 829-837

1089

12498 Goers J, Manning-Bog AB, McCormack AL, Millett IS, Doniach S, et al.

Nuclear localization of alpha-synuclein and its interaction with histones

BIOCHEMISTRY. 2003 JUL 22; 42 (28): 8465-8471

1090

14013 Zhu M, Rajamani S, Kaylor J, Han S, Zhou FM, et al.

The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 JUN 25; 279 (26): 26846-26857

Date / Author / Journal

LCS

GCS

LCR

1091

16873 de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, et al.

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment

NEUROBIOLOGY OF AGING. 2006 MAR; 27 (3): 394-401

1092

17240 Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, et al.

Novel ubiquitin neuropathology in frontotemporal dementia with valosin- containing protein gene mutations

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2006 JUN; 65 (6): 571-581

1093

18668 Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, et al.

The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

JOURNAL OF CLINICAL INVESTIGATION. 2007 MAR; 117 (3): 648-658

110

1094

20273 Geser F, Winton MJ, Kwong LK, Xu Y, Xie SX, et al.

Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam

ACTA NEUROPATHOLOGICA. 2008 JAN; 115 (1): 133-145

1095

1329 TALAMO BR, RUDEL RA, KOSIK KS, LEE VMY, NEFF S, et al.

PATHOLOGICAL-CHANGES IN OLFACTORY NEURONS IN PATIENTS WITH ALZHEIMERS- DISEASE

NATURE. 1989 FEB 23; 337 (6209): 736-739

182

1096

2578 ISHIGURO K, OMORI A, TAKAMATSU M, SATO K, ARIOKA M, et al.

PHOSPHORYLATION SITES ON TAU BY TAU PROTEIN KINASE-I, A BOVINE DERIVED KINASE GENERATING AN EPITOPE OF PAIRED HELICAL FILAMENTS

NEUROSCIENCE LETTERS. 1992 DEC 14; 148 (1-2): 202-206

104

1097

2980 MANDELKOW EM, MANDELKOW E

TAU AS A MARKER FOR ALZHEIMERS-DISEASE

TRENDS IN BIOCHEMICAL SCIENCES. 1993 DEC; 18 (12): 480-483

112

1098

4252 Gritti A, Parati EA, Cova L, Frolichsthal P, Galii R, et al.

Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor

JOURNAL OF NEUROSCIENCE. 1996 FEB 1; 16 (3): 1091-1100

643

1099

4921 Trojanowski JQ, Kleppner SR, Hartley RS, Miyazono M, Fraser NW, et al.

Transfectable and transplantable postmitotic human neurons: A potential ''platform'' for gene therapy of nervous system diseases

EXPERIMENTAL NEUROLOGY. 1997 MAR; 144 (1): 92-97

1100

5084 Crino PB, Trojanowski JQ, Eberwine J

Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity

ACTA NEUROPATHOLOGICA. 1997 JUN; 93 (6): 619-627

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records